These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22136295)

  • 21. Interferon-γ mediates the immunosuppression of bone marrow mesenchymal stem cells on T-lymphocytes in vitro.
    Liang C; Jiang E; Yao J; Wang M; Chen S; Zhou Z; Zhai W; Ma Q; Feng S; Han M
    Hematology; 2018 Jan; 23(1):44-49. PubMed ID: 28581352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal Stromal Cells Derived From Crohn's Patients Deploy Indoleamine 2,3-dioxygenase-mediated Immune Suppression, Independent of Autophagy.
    Chinnadurai R; Copland IB; Ng S; Garcia M; Prasad M; Arafat D; Gibson G; Kugathasan S; Galipeau J
    Mol Ther; 2015 Jul; 23(7):1248-1261. PubMed ID: 25899824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.
    Tse WT; Pendleton JD; Beyer WM; Egalka MC; Guinan EC
    Transplantation; 2003 Feb; 75(3):389-97. PubMed ID: 12589164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autologous mesenchymal stem cells prevent transplant arteriosclerosis by enhancing local expression of interleukin-10, interferon-γ, and indoleamine 2,3-dioxygenase.
    Jui HY; Lin CH; Hsu WT; Liu YR; Hsu RB; Chiang BL; Tseng WY; Chen MF; Wu KK; Lee CM
    Cell Transplant; 2012; 21(5):971-84. PubMed ID: 22449499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor.
    Valencia J; Blanco B; Yáñez R; Vázquez M; Herrero Sánchez C; Fernández-García M; Rodríguez Serrano C; Pescador D; Blanco JF; Hernando-Rodríguez M; Sánchez-Guijo F; Lamana ML; Segovia JC; Vicente Á; Del Cañizo C; Zapata AG
    Cytotherapy; 2016 Oct; 18(10):1297-311. PubMed ID: 27637760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of Immune Suppression Utilized by Canine Adipose and Bone Marrow-Derived Mesenchymal Stem Cells.
    Chow L; Johnson V; Coy J; Regan D; Dow S
    Stem Cells Dev; 2017 Mar; 26(5):374-389. PubMed ID: 27881051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells.
    Ryan JM; Barry F; Murphy JM; Mahon BP
    Clin Exp Immunol; 2007 Aug; 149(2):353-63. PubMed ID: 17521318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of Biological Characteristics and Immunosuppressive Activity between Human Amniotic Mesenchymal Stem Cells and Human Bone Marrow Mesenchymal Stem Cells].
    Hong JQ; Gao Y; Song J; Zhuo WB; Sun HT; Ping BH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):858-64. PubMed ID: 27342523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO.
    Tipnis S; Viswanathan C; Majumdar AS
    Immunol Cell Biol; 2010; 88(8):795-806. PubMed ID: 20386557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of Wnt3a-transduced bone marrow mesenchymal stem cells on the proliferation of T lymphocytes].
    Li ZY; Lu G; Mou WW; Wang CQ; Pan XY; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):688-92. PubMed ID: 22339829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stromal cells augment CD4+ and CD8+ T-cell proliferation through a CCL2 pathway.
    Zhou Y; Day A; Haykal S; Keating A; Waddell TK
    Cytotherapy; 2013 Oct; 15(10):1195-207. PubMed ID: 23845188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord.
    Manochantr S; U-pratya Y; Kheolamai P; Rojphisan S; Chayosumrit M; Tantrawatpan C; Supokawej A; Issaragrisil S
    Intern Med J; 2013 Apr; 43(4):430-9. PubMed ID: 23176558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brief Report: Proteasomal Indoleamine 2,3-Dioxygenase Degradation Reduces the Immunosuppressive Potential of Clinical Grade-Mesenchymal Stromal Cells Undergoing Replicative Senescence.
    Loisel S; Dulong J; Ménard C; Renoud ML; Meziere N; Isabelle B; Latour M; Bescher N; Pedeux R; Bertheuil N; Flecher E; Sensebé L; Tarte K
    Stem Cells; 2017 May; 35(5):1431-1436. PubMed ID: 28142215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation.
    François M; Romieu-Mourez R; Li M; Galipeau J
    Mol Ther; 2012 Jan; 20(1):187-95. PubMed ID: 21934657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon-γ regulates the function of mesenchymal stem cells from oral lichen planus via indoleamine 2,3-dioxygenase activity.
    Zhang Z; Han Y; Song J; Luo R; Jin X; Mu D; Su S; Ji X; Ren YF; Liu H
    J Oral Pathol Med; 2015 Jan; 44(1):15-27. PubMed ID: 25212102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function.
    Ramasamy R; Tong CK; Seow HF; Vidyadaran S; Dazzi F
    Cell Immunol; 2008 Feb; 251(2):131-6. PubMed ID: 18502411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells.
    Trivedi P; Hematti P
    Exp Hematol; 2008 Mar; 36(3):350-9. PubMed ID: 18179856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells.
    English K; Barry FP; Field-Corbett CP; Mahon BP
    Immunol Lett; 2007 Jun; 110(2):91-100. PubMed ID: 17507101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin E2 potentiates mesenchymal stem cell-induced IL-10+IFN-γ+CD4+ regulatory T cells to control transplant arteriosclerosis.
    Hsu WT; Lin CH; Chiang BL; Jui HY; Wu KK; Lee CM
    J Immunol; 2013 Mar; 190(5):2372-80. PubMed ID: 23359497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.